Clinical trial registry record

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT07092618
Last registry update
July 30, 2025
Status
Recruiting
Phase
PHASE2, PHASE3
Sponsor
AgelessRx
Enrollment
150
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 100% confidence

Abstract contains controlled term: metformin.

  • GLP-1 therapies · 100%Title contains controlled term: glp-1. Abstract contains controlled term: glp-1. Source terminology contains: glp-1. Abstract supplies longevity context: healthspan. Study type is explicitly identified as INTERVENTIONAL.
  • Metformin · 100%Abstract contains controlled term: metformin. Source terminology contains: metformin. Abstract supplies longevity context: healthspan. Study type is explicitly identified as INTERVENTIONAL.
  • Rapamycin · 100%Abstract contains controlled term: rapamycin. Source terminology contains: rapamycin. Abstract supplies longevity context: healthspan. Study type is explicitly identified as INTERVENTIONAL.

Source quality 100% · freshness 65%. These are automated routing signals, not medical or evidence-strength ratings.

glp 1 therapiesmetforminrapamycin
Open primary sourceExport JSON